lactic acid has been researched along with lovastatin in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| White, RH; Zhou, D | 1 |
| Botham, KM; Hoang, VQ; Pearce, NJ; Suckling, KE | 1 |
| Fujimoto, S; Ishimoto, A; Nagai, K; Nagasawa, K | 1 |
| Efuet, ET; Keyomarsi, K | 1 |
| Hirano, T; Iseki, K; Itagaki, S; Kobayashi, M; Otsuka, Y | 1 |
| Chiang, CP; Ho, MH; Kuo, MY; Lai, JY; Lee, BS; Lin, SK; Liu, YF | 1 |
| Chen, W; Guan, Q; Hu, X | 1 |
| Chen, HJ; Chen, YW; Hsieh, WL; Lai, CH; Lee, BS; Lee, CC; Wang, YP | 1 |
| Goshu, B; Langert, KA; Stubbs, EB | 1 |
| Hsieh, YP; Lee, BS; Lin, HP; Tu, HP | 1 |
| Du, J; Huang, J; Huang, X; Lin, W; Liu, L; Long, Z; Ma, W; Xie, Y; Zhang, N | 1 |
12 other study(ies) available for lactic acid and lovastatin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Early steps of isoprenoid biosynthesis in Escherichia coli.
Topics: Acetates; Acetic Acid; Bacterial Proteins; Carbon Isotopes; Deuterium; Escherichia coli; Glucose; Hemiterpenes; Isotope Labeling; Lactates; Lactic Acid; Lovastatin; Mass Spectrometry; Organophosphorus Compounds; Ubiquinone | 1991 |
Evaluation of cultured hamster hepatocytes as an experimental model for the study of very low density lipoprotein secretion.
Topics: Animals; Anticholesteremic Agents; Cells, Cultured; Cholesterol; Cholesterol Esters; Cholesterol, Dietary; Cricetinae; Dexamethasone; Lactates; Lactic Acid; Lipoproteins, VLDL; Liver; Lovastatin; Male; Mesocricetus; Models, Biological; Oleic Acid; Oleic Acids; Pyruvates; Pyruvic Acid; Triglycerides | 1995 |
Transport mechanism for lovastatin acid in bovine kidney NBL-1 cells: kinetic evidences imply involvement of monocarboxylate transporter 4.
Topics: Animals; Cattle; Cell Line; Drug Interactions; Hydrogen-Ion Concentration; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Lactic Acid; Lovastatin; Monocarboxylic Acid Transporters; Muscle Proteins; Protein Isoforms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Symporters; Time Factors | 2003 |
Farnesyl and geranylgeranyl transferase inhibitors induce G1 arrest by targeting the proteasome.
Topics: Antineoplastic Agents; Benzamides; Breast Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Enzyme Inhibitors; G1 Phase; Humans; Lactic Acid; Lovastatin; Methionine; Proteasome Endopeptidase Complex; Protein Prenylation; rap1 GTP-Binding Proteins; ras Proteins; Tumor Cells, Cultured; Up-Regulation | 2006 |
Inhibitory effects of statins on human monocarboxylate transporter 4.
Topics: Animals; Atorvastatin; Basigin; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lactic Acid; LLC-PK1 Cells; Lovastatin; Monocarboxylic Acid Transporters; Muscle Proteins; Pyridines; Pyrroles; Simvastatin; Swine; Transfection | 2006 |
Highly efficient release of lovastatin from poly(lactic-co-glycolic acid) nanoparticles enhances bone repair in rats.
Topics: Alkaline Phosphatase; Animals; Bone Regeneration; Cells, Cultured; Cone-Beam Computed Tomography; Delayed-Action Preparations; Drug Carriers; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lactic Acid; Lovastatin; Male; Mandible; Nanoparticles; Osteoblasts; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar | 2011 |
Development of lovastatin-loaded poly(lactic acid) microspheres for sustained oral delivery: in vitro and ex vivo evaluation.
Topics: Administration, Oral; Animals; Biological Availability; Drug Delivery Systems; Drug Stability; Lactic Acid; Lovastatin; Microspheres; Molecular Conformation; Particle Size; Polyesters; Polymers; Rats; Surface Properties | 2015 |
Controlled-release of tetracycline and lovastatin by poly(D,L-lactide-co-glycolide acid)-chitosan nanoparticles enhances periodontal regeneration in dogs.
Topics: Alkaline Phosphatase; Animals; Anti-Bacterial Agents; Bacteria; Bone Regeneration; Chitosan; Delayed-Action Preparations; Dogs; Drug Carriers; Lactic Acid; Lovastatin; Male; Microscopy, Electron, Transmission; Nanoparticles; Osteoblasts; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Tetracycline | 2016 |
Attenuation of experimental autoimmune neuritis with locally administered lovastatin-encapsulating poly(lactic-co-glycolic) acid nanoparticles.
Topics: Animals; Capsules; Disease Models, Animal; Glycols; Guillain-Barre Syndrome; Lactic Acid; Lovastatin; Nanoparticles; Neuritis, Autoimmune, Experimental; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Sciatic Nerve; T-Lymphocytes | 2017 |
Controlled release of lovastatin from poly(lactic-
Topics: Alkaline Phosphatase; Aluminum Compounds; Animals; Calcium Compounds; Cell Differentiation; Delayed-Action Preparations; Dental Pulp; Dental Pulp Capping; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Extracellular Matrix Proteins; Humans; Lactic Acid; Lovastatin; Molar, Third; Nanoparticles; Osteogenesis; Oxides; Phosphoproteins; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Wistar; Sialoglycoproteins; Silicates | 2017 |
Regulation of lactate production through p53/β-enolase axis contributes to statin-associated muscle symptoms.
Topics: Animals; Dichloroacetic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lactic Acid; Lovastatin; Mice; Muscle, Skeletal; Phosphopyruvate Hydratase; Physical Conditioning, Animal; Tumor Suppressor Protein p53 | 2019 |